Innovative genetic tests for everyday life Luminex Licensed Technologies Partners span a broad range of market…
The Faces of Luminex: Ben Treece, Quality Assurance
If a Luminex reagent, assay, or instrument is manufactured in our Austin headquarters, its quality compliance …
Webinar Wednesday: Overcome Biomarker Multiplexing Challenges in Drug Development
Paul Rhyne from BDS Shares Recommended Multiplexing Techniques Paul Rhyne, PhD, Chief Scientific Officer …
The Faces of Luminex: Alan Virden, Hardware Product Services
Preparing documentation and training for Luminex products was a lot easier back when we only sold one instrume…
Webinar Wednesday: James Lederer from Harvard Medical School
Use of xMAP® Technology to Measure Complex Immune Response to Infection in Mice For our fifth Webinar Wednesda…
Luminex® 200™ Resources Make Maintenance More Manageable
New Video Suite Helps You Keep Your Instrument Up and Running Keeping your Luminex® 200™ instrument run…
In Infectious Disease Testing, Flexibility is the Common Theme
Clinical labs that can adapt quickly will produce the best results With the constant pressure to deliver quick…
Webinar Wednesday: Mariano Severgnini from Dana-Farber Cancer Institute
Soluble Biomarker Detection in Cancer Patients Treated with Immunotherapies using xMAP® Technology For our fou…
Delivering the Trifecta
Throughput, Speed, and Insights with Multiplexing The Applied Physiology Laboratory at the University of North…
The Faces of Luminex: Misty Spacek, Budget and Financial Analysis
The Luminex operations couldn’t run smoothly without accurate budgeting, forecasting, and reporting. Mis…